Description
Introduction Of Hertraz 150mg Injection:
Hertraz 150mg Injection contains Trastuzumab, a monoclonal antibody used in the treatment of HER2-positive breast cancer and stomach (gastric) cancer.
Hertraz 150mg Injection is administered only by a trained healthcare professional as an intravenous infusion. Your doctor will decide the dose and frequency based on your condition, weight, and whether it is used alone or combined with other cancer treatments such as chemotherapy or hormone therapy. It should never be self-administered.
Your doctor will check your heart health before starting treatment and monitor it regularly during treatment, since this medicine can affect heart function, especially when combined with certain other chemotherapy drugs. Flu-like symptoms and infusion-related reactions are among the most common effects of this medicine. Inform your doctor if you notice breathing difficulties, irregular heartbeat, or swelling of the face and lips.
Uses Of Hertraz 150mg Injection:
- HER2-Positive Breast Cancer
- HER2-Positive Stomach (Gastric) Cancer
Benefits Of Hertraz 150mg Injection:
1. HER2-Positive Breast Cancer
Some breast cancers have large amounts of the HER2 protein on their surface, which drives the cancer cells to grow and multiply. Hertraz 150mg Injection works by binding to HER2, blocking these growth signals and helping slow tumor growth in early-stage and metastatic breast cancer.
2. HER2-Positive Stomach Cancer
In HER2-positive stomach cancer, Hertraz 150mg Injection, usually combined with chemotherapy, helps target and slow the growth of cancer cells, supporting the overall treatment plan.
Side effects of Hertraz 150mg Injection:
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Common side effects of Trastuzumab:
- Chills
- Fever
- Flu-like symptoms
- Nausea
- Vomiting
- Headache
- Diarrhea
- Fatigue
- High or low blood pressure
Machanism Of Action Of Hertraz 150mg Injection:
Hertraz Injection contains Trastuzumab, a recombinant monoclonal antibody. It works by selectively binding to the HER2 receptor found in large amounts on the surface of certain cancer cells. This blocks the growth signals the cancer cells rely on, slowing their growth and division, and may also help the immune system recognize and destroy them.

Reviews
There are no reviews yet.